| Brand Name | REVANESSE VERSA+ 1.2 ML |
| Common Device Name | REVANESSE VERSA+ |
| Manufacturer (Section D) |
| PROLLENIUM MEDICAL TECHNOLOGIES INC. |
| 38 industrial parkway n, |
| aurora, on L4G 4 C3 |
| CA L4G 4C3 |
|
| Manufacturer Contact |
|
ario
khoshbin
|
| 138 industrial parkway n |
| aurora, on L4G 4-C3
|
|
CA
L4G 4C3
|
|
| MDR Report Key | 21143557 |
| Report Number | 3004423487-2024-00029 |
| Device Sequence Number | 9236847 |
| Product Code |
LMH
|
| UDI-Device Identifier | 10669808001038 |
| UDI-Public | 10669808001038 |
| Combination Product (Y/N) | Y |
| PMA/510(K) Number | P160042 S004 |
| Number of Events Summarized | 1 |
| Summary Report (Y/N) | N |
| Serviced by Third Party (Y/N) | N |
| Reporter Type |
Manufacturer
|
| Report Source |
Health Professional |
| Initial Reporter Occupation |
Administrator/Supervisor
|
| Type of Report
| Initial |
| Report Date (Section B) |
01/07/2025 |
| 1 Device was Involved in the Event |
|
| 1 Patient was Involved in the Event |
|
| Is this an Adverse Event Report? |
Yes
|
| Is this a Product Problem Report? |
No
|
| Operator of Device |
Health Professional
|
| Device Expiration Date | 03/06/2026 |
| Device Model Number | 40083 |
| Device Lot Number | 24C127 |
| Was Device Available for Evaluation? |
No
|
| Type of Report(Section G) | Thirty-Day |
| Initial Date Received by Manufacturer | 12/12/2024 |
| Initial Report FDA Received Date | 01/13/2025 |
| Was Device Evaluated by Manufacturer? (Y/N) |
No
|
| Date Device Manufactured | 02/28/2024 |
| Is the Device Labeled for Single Use? (Y/N) |
Yes
|
Is This a Single-Use Device that was Reprocessed and Reused on a Patient? (Y/N) |
No
|
| Usage of Device |
Initial
|
| Patient Sequence Number | 1 |
| Patient Age | 68 YR |
| Patient Sex | Female |
| Patient Ethnicity | Non Hispanic |
| Patient Race | American Indian Or Alaskan Native, Black Or African American, White |
|
|